Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Nuclear pharmacy: background and history of the development and current status (Europe)

  • At: 2006 FIP Congress in Salvadore (Brazil)
  • Type: Presentation
  • By: HARTMAN, Neil (Addenbrooke's Hospital, Nuclear Medicine, Cambridge, United Kingdom)
  • Abstract:

    Iodine-131 treatment was introduced in Europe in the 1940s just after the war soon after the USA. The UK and France were the first countries to implement radioiodine therapy, since they had the first European reactors, but this was soon repeated in other states (Norway being the first of the smaller states to have a reactor in 1951). In the 1950s

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses